PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
10-Dec-2025 Sinceri Senior Living Expands Texas Presence Through New Partnership with CareTrust REIT ACCESS Newswire
10-Dec-2025 PLL Therapeutics opens subsidiary in New Zealand to accelerate ALS (Amyotrophic Lateral Sclerosis) treatment and early diagnostics breakthroughs Andrew Lloyd Associates
10-Dec-2025 Bariatric Surgery Devices Market Insights | Leading Companies and New Entrants in the Healthcare Sector Medi-Tech Insights
10-Dec-2025 Igyxos Biotherapeutics Announces Positive Results from Phase 1 Trial of IGX12, its First-in-Class Monoclonal Antibody for the Treatment of Male and Female Infertility Igyxos Biotherapeutics
10-Dec-2025 Igyxos Biotherapeutics Announces Positive Results from Phase 1 Trial of IGX12, its First-in-Class Monoclonal Antibody for the Treatment of Male and Female Infertility Igyxos Biotherapeutics
10-Dec-2025 Medical Care Technologies Inc. (OTC PINK:MDCE) Subsidiary Real Game Used Achieves Major Milestone in High-End Memorabilia Authentication ACCESS Newswire
10-Dec-2025 Polpharma Biologics and Libbs Farmacêutica Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases Businesswire
10-Dec-2025 IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q2 results. We believe more positive clinical data and progress in 2025/26 to be strong catalysts for stock. Raising P/T to $4.75." ACCESS Newswire
10-Dec-2025 FDA Approves Renewal of Canalevia-CA1, Jaguar Health's Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs ACCESS Newswire
10-Dec-2025 Sant' Andrea University Hospital to Integrate GE HealthCare and Tribun Health's Enterprise Imaging and Digital Pathology Solutions to Help Improve Patient Care ACCESS Newswire
10-Dec-2025 Oxford BioTherapeutics Enters into a Strategic Collaboration with GSK to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer Oxford BioTherapeutics
10-Dec-2025 Provepharm expands presence in medical dyes and enters fluorescence era Provepharm
10-Dec-2025 UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder UCB
10-Dec-2025 Modular Medical Announces Pricing of $4.68 Million Public Offering ACCESS Newswire
10-Dec-2025 Model N Launches Data nSights: Real-Time Analytics to Drive Action and Optimize Net Revenue Model N
10-Dec-2025 Supreme Group Unifies Amendola Communications and Health+Commerce to Launch Supreme Communications Supreme Group
10-Dec-2025 Provepharm expands presence in medical dyes and enters fluorescence era Andrew Lloyd Associates
10-Dec-2025 Senzime Unveils the Next Set of Innovations in Neuromuscular Monitoring With the Launch of EMGINE Sirius ACCESS Newswire
10-Dec-2025 Donate Toys for Shrooms: Zide Door Joins Oakland's Mistah F.A.B.'s Toys for Joy ACCESS Newswire
10-Dec-2025 Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator Businesswire